Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 971-980 of 11953

Edit search filters
  1. A Study to to Determine the Impact of a Mobile Health Application on Rheumatoid Arthritis Shared Decision Making

    Rochester, MN

  2. A Study of Pharmacogenomics (PGx) Results and Clinical Data of Chronic Pain Patients to Assess Current and Future Therapeutic Relevance

    Rochester, MN

  3. A Study Comparing The Safety And Effectiveness Of Lonapegsomatropin With Placebo And Somatropin In Adults With Growth Hormone Deficiency

    Rochester, MN

  4. The ExTINGUISH Trial Of Inebilizumab In NMDAR Encephalitis (ExTINGUISH)

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  5. GATE1: A Multicenter Phase II Study Of Pirtobrutinib, Rituximab And Venetoclax Combination Therapy For Patients With Previously Untreated Mantle Cell Lymphoma

    Rochester, MN

  6. A Study to Evaluate Molecular Mechanisms of Exercise Benefits in Insulin Resistant People

    Rochester, MN

  7. A Study to Analyze The Impact of Pharmacist Consultation in Patients Beginning Intravenous Cancer Treatment

    La Crosse, WI

  8. A Study Of TAK-062 In Treatment Of Active Celiac Disease In Participants Attempting A Gluten-Free Diet

    Scottsdale/Phoenix, AZ, Rochester, MN

  9. A Study To Evaluate Safety, And Efficacy Of SUVN-G3031 In Patients With Narcolepsy With And Without Cataplexy

    Scottsdale/Phoenix, AZ

  10. Symptom Monitoring Using Patient-Report To Improve Medication Use

    Rochester, MN

.

Mayo Clinic Footer